Related Experiment Video
Updated: Feb 4, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Role of phage-antibiotic combination in reducing antibiotic resistance in Staphylococcus aureus
Ara Jo1, Jeongjin Kim1, Tian Ding2
11Department of Medical Biomaterials Engineering and Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon, Gangwon, 24341 Korea.
Abstract:
This study was designed to evaluate the effect of phage-antibiotic synergy in reducing antibiotic resistance. The initial numbers of Staphylococcus aureus treated with ciprofloxacin, phages, and combination were significantly reduced by 3.47, 4.62, and 5.75 log CFU/mL, respectively, at the early 12 h of incubation. The combination treatment most effectively inhibited the growth of S. aureus, showing more than 4 log reduction in 18 h of incubation at 37°C. The significant reduction in biofilm formation by S. aureus was observed at the combination treatment (3.91 log). Ciprofloxacin-treated S. aureus cells became resistant to both ciprofloxacin and phage, showing the mutant frequencies of 27% and 25%, respectively, whereas no antibiotic- and phage-resistant S. aureus cells were observed at the combined treatment of ciprofloxacin and phages. These results provide useful information for reducing the risk of antibiotic resistance in human and food animals.
Insights
Phage and antibiotic combination therapy effectively reduces Staphylococcus aureus growth and biofilm formation. This synergistic approach prevents the development of antibiotic and phage resistance in bacteria.
Area of Science:
- Microbiology
- Bacteriology
- Antimicrobial Resistance
Background:
- Antibiotic resistance poses a significant threat to public health.
- Staphylococcus aureus is a common pathogen associated with various infections.
- Novel strategies are needed to combat antibiotic-resistant bacteria.
Purpose of the Study:
- To evaluate the synergistic effect of phage and antibiotic combination therapy against Staphylococcus aureus.
- To assess the impact of this combination on bacterial growth, biofilm formation, and resistance development.
Main Methods:
- Treatment of Staphylococcus aureus with ciprofloxacin, phages, or a combination thereof.
- Quantification of bacterial reduction over time.
- Assessment of biofilm formation.
- Determination of mutant frequencies for antibiotic and phage resistance.
Main Results:
- Combination therapy demonstrated the most effective inhibition of S. aureus growth, achieving over 4 log reduction in 18 hours.
- Significant reduction in biofilm formation was observed with combination treatment.
- While ciprofloxacin alone induced resistance to both antibiotic and phage, the combination therapy prevented the emergence of resistant strains.
Conclusions:
- Phage-antibiotic synergy is a promising strategy for controlling Staphylococcus aureus infections.
- Combination therapy effectively reduces bacterial load and biofilm formation.
- This approach mitigates the risk of developing antibiotic and phage resistance, offering a potential solution for clinical applications.
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Role of Reduced Coenzymes NADH and FADH₂
The Roles of Bacteria and Fungi in Plant Nutrition
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Resistivity

